The anatomical basis for transcutaneous auricular vagus nerve stimulation
The array of end organ innervations of the vagus nerve, coupled with increased basic
science evidence, has led to vagus nerve stimulation (VNS) being explored as a …
science evidence, has led to vagus nerve stimulation (VNS) being explored as a …
[HTML][HTML] Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis
ŁJ Walczak-Nowicka, M Herbet - International journal of molecular …, 2021 - mdpi.com
Acetylcholinesterase (AChE) plays an important role in the pathogenesis of
neurodegenerative diseases by influencing the inflammatory response, apoptosis, oxidative …
neurodegenerative diseases by influencing the inflammatory response, apoptosis, oxidative …
Transcutaneous vagus nerve stimulation modulates default mode network in major depressive disorder
J Fang, P Rong, Y Hong, Y Fan, J Liu, H Wang… - Biological …, 2016 - Elsevier
Background Depression is the most common form of mental disorder in community and
health care settings and current treatments are far from satisfactory. Vagus nerve stimulation …
health care settings and current treatments are far from satisfactory. Vagus nerve stimulation …
Effects of rosmarinic acid on nervous system disorders: an updated review
M Ghasemzadeh Rahbardar… - … Archives of Pharmacology, 2020 - Springer
Nowadays, the worldwide interest is growing to use medicinal plants and their active
constituents to develop new potent medicines with fewer side effects. Precise dietary …
constituents to develop new potent medicines with fewer side effects. Precise dietary …
The vigilance regulation model of affective disorders and ADHD
According to the recently proposed vigilance model of affective disorders (vigilance in the
sense of “brain arousal”), manic behaviour is partly interpreted as an autoregulatory attempt …
sense of “brain arousal”), manic behaviour is partly interpreted as an autoregulatory attempt …
Transcutaneous vagus nerve stimulation modulates amygdala functional connectivity in patients with depression
J Liu, J Fang, Z Wang, P Rong, Y Hong, Y Fan… - Journal of Affective …, 2016 - Elsevier
Background The amygdala is a key region in emotion processing, and studies have
suggested that amygdala-frontal functional connectivity deficits could be modulated by …
suggested that amygdala-frontal functional connectivity deficits could be modulated by …
Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation
Rosmarinus officinalis (R. officinalis), a culinary aromatic and medicinal plant, is very rich in
polyphenols and flavonoids with high antioxidant properties. This plant was reported to exert …
polyphenols and flavonoids with high antioxidant properties. This plant was reported to exert …
The catecholaminergic–cholinergic balance hypothesis of bipolar disorder revisited
J van Enkhuizen, DS Janowsky, B Olivier… - European journal of …, 2015 - Elsevier
Bipolar disorder is a unique illness characterized by fluctuations between mood states of
depression and mania. Originally, an adrenergic–cholinergic balance hypothesis was …
depression and mania. Originally, an adrenergic–cholinergic balance hypothesis was …
Antidepressant and anxiolytic effects of amentoflavone isolated from Cnestis ferruginea in mice
The root decoction of Cnestis ferruginea (CF) Vahl DC (Connaraceae) is used in traditional
African medicine in the management of psychiatric disorders. This study presents the …
African medicine in the management of psychiatric disorders. This study presents the …
M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine
JM Witkin, C Overshiner, X Li, JT Catlow… - … of Pharmacology and …, 2014 - ASPET
Scopolamine produces rapid and significant symptom improvement in patients with
depression, and most notably in patients who do not respond to current antidepressant …
depression, and most notably in patients who do not respond to current antidepressant …